ELENI ALBANI | Health | Best Researcher Award

Mrs. ELENI ALBANI | Health | Best Researcher Award

Mrs. ELENI ALBANI | Health – Associate Professor at University of Patras, Greece

Dr. Eleni N. Albani is a dedicated academic and healthcare researcher whose work bridges the disciplines of pediatric nursing, primary health care, and inflammatory bowel disease (IBD). Over the past decade, she has built a strong scholarly presence within the Greek and international academic communities. With numerous collaborations and a growing number of citations, Dr. Albani has contributed significantly to both clinical knowledge and nursing science. Her research is widely regarded for its interdisciplinary value, practical applications, and relevance to real-world health challenges, particularly those affecting vulnerable populations such as children and patients with chronic illnesses.

Profile Verified:

Google Scholar

Education:

Dr. Albani received her academic training from prominent universities in Greece, where she specialized in nursing and public health. Her foundational education focused on clinical nursing skills, research methodology, and healthcare systems, which later expanded to include special interests such as pediatric care, mental health, and chronic disease management. Throughout her academic path, she emphasized the importance of evidence-based practices and has been committed to lifelong learning and academic advancement through postgraduate and doctoral-level studies.

Experience:

With years of professional experience in academic nursing, Dr. Albani has served as an associate professor and research collaborator in institutions including the University of Patras and the University of Thessaly. Her career includes active roles in teaching undergraduate and postgraduate students, conducting research projects, and publishing in peer-reviewed journals. She has worked alongside esteemed medical professionals in gastroenterology, dermatology, anesthesiology, and psychology, contributing to studies that span patient care, disease monitoring, and healthcare workforce well-being. Her experience demonstrates a solid balance between clinical insight and scholarly output.

Research Interests:

Dr. Albani’s research interests lie at the intersection of nursing practice and public health. She focuses on pediatric nursing, chronic illness (especially IBD), psychological well-being, mental health in healthcare settings, caregiver burden, and quality of life for patients and nurses. Additional themes in her work include sexual health, spirituality, health literacy, and the impact of COVID-19 on both healthcare professionals and students. Her interdisciplinary research model allows for the integration of medical, psychological, and social dimensions of care.

Awards:

While specific awards have not been listed, Dr. Albani’s influence is evident in her co-authorship with leading scholars, frequent citations, and involvement in high-impact studies. Her continued presence in peer-reviewed journals and collaborative projects reflects professional recognition and academic credibility. Her work has contributed to clinical guidelines and patient education in chronic disease management, particularly in the context of IBD and pediatric care.

Publications 📚:

  1. 📘 Inflammatory bowel disease and sexual function in male and female patients: an update on evidence in the past ten years (2015, Journal of Crohn’s and Colitis) – Cited by 63. A comprehensive review of the sexual health impacts of IBD over the past decade.
  2. 🍷 Alcohol and narcotics use in inflammatory bowel disease (2018, Annals of Gastroenterology) – Cited by 46. Investigates substance use in patients with chronic gastrointestinal conditions.
  3. 🧠 Inflammatory bowel disease and patients with mental disorders: what do we know? (2021, Journal of Clinical Medicine Research) – Cited by 31. Links between mental health disorders and IBD outcomes.
  4. 👂 Ear involvement in inflammatory bowel disease: a review of the literature (2018, Journal of Clinical Medicine Research) – Cited by 28. A rare topic exploring ENT complications in IBD patients.
  5. 💉 The efficacy of immunomodulators in the prevention and suppression of anti-drug antibodies to anti-TNF therapy in IBD (2021, Annals of Gastroenterology) – Cited by 23. Focuses on pharmacological management of IBD.
  6. 😷 The impact of mental health, subjective happiness and religious coping on the quality of life of nursing students during the COVID-19 pandemic (2022, Wiadomości Lekarskie) – Cited by 11. COVID-era research on nursing students’ mental health.
  7. 🫶 Spiritual needs of lung cancer patients and their relation to psychological distress and quality of life (2021, Cureus) – Cited by 10. Addresses emotional and spiritual support in oncology nursing.

Conclusion:

Dr. Eleni N. Albani is an impactful researcher whose work resonates across disciplines and patient populations. Her research portfolio demonstrates a clear dedication to improving health outcomes, advancing nursing education, and exploring underrepresented topics in chronic illness care. With solid academic metrics—315 citations, h-index 10, i10-index 11—and a focused commitment to collaborative science, she is a strong candidate for the Best Researcher Award. Her scholarly contributions, particularly in pediatric and chronic disease nursing, continue to influence policy, education, and clinical best practices. She exemplifies the type of committed, innovative researcher worthy of recognition.

 

 

 

Malcolm Leissring | Control of gene expression | Best Researcher Award

Prof. Dr. Malcolm Leissring | Control of gene expression | Best Researcher Award

Prof. Dr. Malcolm Leissring | Control of gene expression – Research Professor at University of California, Irvine, United States

Dr. Malcolm Arthur Leissring is a distinguished neuroscientist whose research has made significant contributions to the understanding and potential treatment of Alzheimer’s disease. Over a career spanning more than two decades, he has built a strong reputation as both an academic and an innovator, blending deep scientific expertise with leadership in biotechnology. He has served in research and executive positions at globally respected institutions and biotech firms, driving both foundational discoveries and translational advancements. His career reflects a commitment to improving human health through molecular neuroscience, aging biology, and the development of therapeutic strategies for neurodegenerative diseases.

Profile Verified

Google Scholar | ORCID | Scopus

Education

Dr. Leissring’s academic journey began with undergraduate and graduate studies in biology, culminating in a Ph.D. in Neurobiology. His doctoral research laid the groundwork for a lifelong focus on the molecular basis of neurological diseases. He then pursued postdoctoral training at the University of California, Irvine, and later at Harvard Medical School. These formative academic experiences provided him with rigorous training in neuroscience and equipped him with the tools to conduct high-impact, disease-relevant research.

Experience

Dr. Leissring’s professional experience is both broad and distinguished. He has held academic appointments at The Scripps Research Institute, Mayo Clinic, and the University of California, Irvine. He has also served in leadership roles at biotech and pharmaceutical companies, including as President and Chief Scientific Officer at DREAMADERM Inc. and Pacific Software Inc., and as Chief Science Officer at KRTL Biotech. His dual roles in academia and industry reflect his ability to translate research into actionable medical applications. Additionally, he leads the Auguste Deter Foundation, which focuses on Alzheimer’s prevention and awareness.

Research Interests

Dr. Leissring’s primary research interests revolve around the molecular and cellular mechanisms underlying Alzheimer’s disease, with a focus on amyloid-beta metabolism, calcium signaling, and insulin-degrading enzyme (IDE) function. His pioneering work has helped establish the role of proteolytic degradation in the accumulation of neurotoxic peptides, a key pathological hallmark of Alzheimer’s. He has also explored the biochemical overlap between aging, neurodegeneration, and metabolic diseases such as diabetes, making his research highly interdisciplinary and medically significant.

Awards

Dr. Leissring has received numerous prestigious awards and honors in recognition of his research excellence. These include the National Research Service Award (NIMH and NIA), the Alzheimer’s Association New Investigator and Investigator-Initiated Research Grants, the Ellison Medical Foundation New Scholar Award, and the American Diabetes Association Career Development Award. His work has also been supported by the GHR Foundation, the American Health Assistance Foundation, and UC Irvine’s Applied Innovation Technology Development Award, demonstrating broad recognition of his scientific impact and innovation.

Publications 📚

  1. Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
    Neuron, 2003Cited by 951
  2. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders
    Trends in Neurosciences, 2000Cited by 636
  3. Proteolytic degradation of amyloid β-protein
    Cold Spring Harbor Perspectives in Medicine, 2012Cited by 465
  4. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice
    The Journal of Cell Biology, 2000Cited by 429
  5. A physiologic signaling role for the γ-secretase-derived intracellular fragment of APP
    Proceedings of the National Academy of Sciences (PNAS), 2002Cited by 370
  6. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid β-protein
    The American Journal of Pathology, 2004Cited by 351
  7. Alternative translation initiation generates a novel isoform of insulin-degrading enzyme targeted to mitochondria
    Biochemical Journal, 2004Cited by 205

Conclusion

Dr. Malcolm Leissring stands out as a leader in neuroscience and Alzheimer’s research, with a career defined by high-impact publications, prestigious awards, and translational innovation. His scientific achievements have advanced our understanding of neurodegenerative disease mechanisms and opened new paths for therapeutic intervention. With a strong record of leadership, interdisciplinary insight, and a commitment to improving public health, Dr. Leissring is exceptionally well-qualified for the Best Researcher Award. His work continues to inspire new approaches and collaborations in the global fight against Alzheimer’s disease.